Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: NZ$2.21 M
• Last 3 months FTD volume: NZ$29.33 M
• Last year FTD volume: NZ$29.33 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	NZ$48.74 M	NZ$0.23 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	NZ$20.22 M	NZ$45.29 M	🇺🇸 USA
AbbVie ABBV	NZ$75.4 M	NZ$0.15 B	🇺🇸 USA
Illumina ILMN	NZ$43.22 M	NZ$71.6 M	🇺🇸 USA
Biogen BIIB	NZ$7.66 M	NZ$69.08 M	🇺🇸 USA
Pfizer PFE	NZ$50.21 M	NZ$0.38 B	🇺🇸 USA
Johnson & Johnson JNJ	NZ$70.18 M	NZ$0.32 B	🇺🇸 USA
Eli Lilly LLY	NZ$41.73 M	NZ$0.14 B	🇺🇸 USA
Merck MRK	NZ$14.45 M	NZ$88.44 M	🇺🇸 USA